These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17261969)

  • 1. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2007 Feb; 5(54):9-14. PubMed ID: 17261969
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy in Alzheimer disease].
    Kovács T
    Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison table: drugs for Alzheimer's disease.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):e160-e161. PubMed ID: 28922344
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dementia].
    Diehl RR
    Fortschr Neurol Psychiatr; 2003 Nov; 71(11):617-28. PubMed ID: 14608514
    [No Abstract]   [Full Text] [Related]  

  • 7. New developments in the treatment of Alzheimer's disease.
    J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Alzheimer's disease].
    Bombois S; Lebert F; Vellas B; Pasquier F
    Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].
    MMW Fortschr Med; 2003 Jun; 145(23):60. PubMed ID: 12854234
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer's disease: will advances made in the past turn the tide?
    Semla TP
    Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.
    Robinson M; Rowett D; Leverton A; Mabbott V
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):659-64. PubMed ID: 19548222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supportive approaches for Alzheimer disease.
    Davis NJ; Hendrix CC; Superville JG
    Nurse Pract; 2011 Aug; 36(8):22-9. PubMed ID: 21747305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
    Rabins PV; Lyketsos CG
    Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of Alzheimer dementia].
    Skausig OB; Laugesem LP; Jensen T
    Ugeskr Laeger; 2003 Jul; 165(29):2899; author reply 2899-900. PubMed ID: 12908363
    [No Abstract]   [Full Text] [Related]  

  • 15. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005].
    Wellhöfer B
    Dtsch Med Wochenschr; 2006 Feb; 131(6):284. PubMed ID: 16463237
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs for vascular dementia.
    Korczyn AD
    Lancet Neurol; 2007 Sep; 6(9):749-51. PubMed ID: 17706553
    [No Abstract]   [Full Text] [Related]  

  • 17. When should drug treatment be started for people with dementia?
    Singh B; O'Brien JT
    Maturitas; 2009 Mar; 62(3):230-4. PubMed ID: 19201114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
    Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
    Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Also consider non-cognitive disorders].
    Krankenpfl J; 2005; 43(7-10):211-2. PubMed ID: 16515283
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA approves groundbreaking Alzheimer's drug.
    Provider; 2004 Feb; 30(2):24, 27. PubMed ID: 14964917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.